The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
70 - 290 jobs Number of planned job losses
Announcement Date
20 June 2008
Employment effect (start)
1 December 2009
Foreseen end date
1 January 2010
Description
The pharmaceutical company Glaxo Smith Kline has announced the closure of its manufacturing site in Fleurus (Hainaut) in December 2009 and the relocation of its activities to Rixensart (Brabant Wallon). Out of 290 workers employed at the site, 70 will take early retirement; it is still unknown the number of workers who will be offered to work at the site of Rixensart.
Sources
2 July 2008: Le Soir
21 June 2008: Le Soir
Citation
Eurofound (2008), Glaxo Smith Kline, Relocation in Belgium, factsheet number 66924, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/66924.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
